Neuroprotective effects of salidroside against 6-OHDA-induced oxidative stress in PC12 cells

Li, Minyan; Wang, Sha; Fu, Chaomei; Chen, Hongyu; Su, Yeping; Wu, Po-Liang; Yan, Xinhao; Gao, Juanjuan

doi:10.1039/d3nj01746j

New J. Chem.

2023

DOI: 10.1039/d3nj01746j

|View full text |Cite

Neuroprotective effects of salidroside against 6-OHDA-induced oxidative stress in PC12 cells

Minyan Li¹,

Sha Wang²,

Chaomei Fu³

et al.

Abstract: Parkinson's disease (PD) is the second-most common neurodegenerative disease characterized by oxidative stress (OS) in the development and progression of PD. This study determined the neuroprotective effects of Salidroside (Sal)....

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease

Zheng,

Liu,

Gao

et al. 2024

Small

View full text Add to dashboard Cite

Parkinson's disease (PD) is currently the second most incurable central neurodegenerative disease resulting from various pathogenesis. As the “energy factory” of cells, mitochondria play an extremely important role in supporting neuronal signal transmission and other physiological activities. Mitochondrial dysfunction can cause and accelerate the occurrence and progression of PD. How to effectively prevent and suppress mitochondrial disorders is a key strategy for the treatment of PD from the root. Therefore, the emerging mitochondria‐targeted therapy has attracted considerable interest. Herein, the relationship between mitochondrial dysfunction and PD, the causes and results of mitochondrial dysfunction, and major strategies for ameliorating mitochondrial dysfunction to treat PD are systematically reviewed. The study also prospects the main challenges for the treatment of PD.

show abstract

Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease

Zheng,

Liu,

Gao

et al. 2024

Small

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Neuroprotective effects of salidroside against 6-OHDA-induced oxidative stress in PC12 cells

Abstract: Parkinson's disease (PD) is the second-most common neurodegenerative disease characterized by oxidative stress (OS) in the development and progression of PD. This study determined the neuroprotective effects of Salidroside (Sal)....

Cited by 1 publication

References 32 publications

Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease

Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease

Contact Info

Product

Resources

About